Verve Therapeutics Aktie News & Pressemeldungen

Verve Therapeutics Eulerpool Nieuws

9-9-2024, 01:28:19

Verve Therapeutics im Fokus: Kontroverser Favorit der Short Seller

16-12-2024, 10:41:03

Aufschwung und Abschwung: Verschiebungen im KMU-Segment und spannende Einzelwerte

17-6-2025, 15:20:10

Eli Lilly übernimmt Verve Therapeutics: Ein Durchbruch in der Geneditierung

17-6-2025, 16:13:16

Spannungen in Nahost belasten US-Börsen: Trump und unsichere Konjunktur sorgen für Zurückhaltung

18-6-2025, 08:31:52

Sorge um den Nahen Osten treibt Ölpreise und bewegt Börsen

Verve Therapeutics Aandeel Nieuws

Verve Therapeutics wordt door vele journalisten en beleggers wereldwijd gevolgd. De meest actuele Verve Therapeutics nieuwsberichten verzamelen we hier.

29 juli ·
Yahoo
Verve Therapeutics (VERV) Reported Results From its Heart-2 Phase 1b Trial for VERVE-102
25 juli ·
Yahoo
Lilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
24 juli ·
Yahoo
Lilly and Verve announce expiration of Verve tender offer
23 juli ·
Yahoo
Eli Lilly Advances Pipeline and Gene Focus With Verve Acquisition
14 juli ·
Yahoo
Biotech Stocks Are Ready to Rebound. 3 to Watch Now.
13 juli ·
Yahoo
Trump Says 200% Pharma Tariffs Are Coming. Wall Street Shrugs.
7 juli ·
Yahoo
Prime Medicine stock soars amid gene editing sector momentum
7 juli ·
Yahoo
Intellia Gains 29.8% in a Month: How Should You Play the Stock?
27 juni ·
Yahoo
BMO downgrades Verve Therapeutics saying Lilly buyout deal caps upside
26 juni ·
SeekingAlpha
Eli Lilly: I've Learned Not To Fight Against The Market (Downgrade)

Verve Therapeutics Aandeel Persberichten

Verve Therapeutics publiceert regelmatig berichten die relevant zijn voor investeerders op de bedrijfswebsite.

Professional-grade financial intelligence

20M+ securities. Real-time data. Institutional insights.

Vanaf 2 € veiliggesteld

Trusted by professionals at Goldman Sachs, BlackRock, and JPMorgan